With this certification, Clevergene through its clinical diagnostics vertical The Gene Lab is launching a host of genetic tests including Non Invasive Prenatal Testing (NIPT), preimplantation genetic screening, Products of Conception (POC) genetic testing as well as genetic counselling services
Clevergene, a deep tech genomics company received the PCPNDT (Pre-Conception and Pre-Natal Diagnostic Techniques) license and will now be offering prenatal diagnostics and pre-implantation genetic screening tests.
With this certification, Clevergene through its clinical diagnostics vertical The Gene Lab is launching a host of genetic tests that will improve outcomes of expectant parents and those planning a baby; these include Non Invasive Prenatal Testing (NIPT) for detecting chromosomal aneuploidy in foetuses, preimplantation genetic screening, Products of Conception (POC) genetic testing as well as genetic counselling services.
The NIPT tests will be able to examine cell-free DNA found in maternal blood originating from the foetus to screen for chromosome abnormalities, including Down syndrome, Edwards syndrome, Patau syndrome, and triploidy. The screening test can be performed as early as nine weeks of gestation and there is no risk to the foetus.